Navigation Links
Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
Date:1/25/2011

CAMBRIDGE, Mass., Jan. 25, 2011 /PRNewswire/ -- Michael Porter, Ph.D., has joined the board of directors of Merrimack Pharmaceuticals, Inc., a privately held biotechnology company focused on the discovery and development of novel treatments for cancer.

(Photo:  http://photos.prnewswire.com/prnh/20110125/NE34069 )

Professor Porter, the Bishop William Lawrence University Professor at Harvard Business School, is recognized as a leading authority on competitive strategy, the competitiveness and economic development of nations, states, and regions, and the application of competitive principles to social problems such as health care, the environment, and corporate responsibility. Harvard University and Harvard Business School jointly created the Institute for Strategy and Competitiveness dedicated to furthering Professor Porter’s research. In addition, he has founded three non-profit organizations: The Initiative for a Competitive Inner City (ICIC), the Center for Effective Philanthropy and FSG-Social Impact Advisors.

”Michael’s global expertise in the strategic development of commercial organizations and his vision for how to transform healthcare will serve as exceptional assets to Merrimack as we advance a leading portfolio of novel molecular medicines and molecular diagnostics,” said Gary Crocker, Chairman of the Board. “Michael has served as a strategic advisor to the Company, providing invaluable guidance from our earliest days. We are excited to welcome him formally to the Board as we look to execute on a significant period of growth.”

Professor Porter holds a Bachelor’s degree in aerospace engineering from Princeton University where he was elected to Phi Beta Kappa and Tau Beta Pi, a Master’s degree in Business Administration with high distinction from Harvard Business School where he was a George F. Baker Scholar and
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
2. Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
3. Merrimack Pharmaceuticals to Present at the 2010 Stifel Nicolaus Healthcare Conference
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has ... Market - Global Forecasts to 2019" report to ... market is estimated to grow expected to reach $9.37 ... 2014 to 2019. Factors such ... financial constraints, increasing privatization in the healthcare sector, and ...
(Date:7/28/2015)... CITY , July 28, 2015  PD-Rx ... today announced that it has partnered with Dobson ... Infrastructure as a Service (IaaS) product. ... medical practices across the United States.  Using Dobson ... disaster recovery and business continuity, ensure regulatory compliance, ...
(Date:7/28/2015)... Fla. , July 28, 2015  For many ... their researchers, physicians and other inventors can be a ... market is difficult, and successes are rare. ... wants to change that. Medical Device Investments ... licensed from universities, hospitals and physicians. MDI develops, manufactures ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2PD-Rx Partners With Dobson Technologies 2Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2
... Preserve Community Pharmacy Access NOW!  (PCPAN) coalition today blasted ... (ESI) for slighting and devaluing community pharmacists in ... of the company,s Q4 2011 Earnings Call.  On the ... is LIPITOR, drugs are drugs and it shouldn,t matter ...
... Ariz., Feb. 27, 2012  Ventana Medical Systems, Inc. (Ventana), a ... the U.S. Food and Drug Administration (FDA) for the ... with the VENTANA iScan Coreo Au scanner ... only company offering an FDA cleared Ki-67 image analysis ...
Cached Medicine Technology:Nationwide Coalition Blasts ESI CEO George Paz for Slighting Community Pharmacists 2Nationwide Coalition Blasts ESI CEO George Paz for Slighting Community Pharmacists 3Ventana Receives FDA Clearance for Ki-67 (30-9) Image Analysis and Digital Read Applications 2
(Date:7/28/2015)... VA (PRWEB) , ... July 28, 2015 , ... ... ), announced today that the company is in full support of National Immunization ... and sometimes deadly diseases. To stay protected against serious illnesses like the flu, ...
(Date:7/28/2015)... ... July 28, 2015 , ... Women in Technology (WIT), the premier organization ... over 20 years, has selected Lisa Dezzutti, CEO and president at Market Connections, Inc. ... excited to serve this organization that empowers women to thrive and excel in the ...
(Date:7/28/2015)... ... July 28, 2015 , ... Egg freezing is ... to help ensure future fertility. As Dr. Michael Kettel explained in an ... an option that wasn’t available for previous generations who had to make choices between ...
(Date:7/28/2015)... ... ... According to WFTV on July 15th heroin overdose rates have increased by ... recent statistic Orlando suffers at least one death weekly as a direct result of ... enforcement officials are struggling to keep apace with its distribution. Officers rely on inside ...
(Date:7/28/2015)... Wayne, PA (PRWEB) , ... July 28, 2015 ... ... that its Board of Directors has authorized the Company, from time to time ... with an aggregate value of up to $25 million. Repurchases will be made ...
Breaking Medicine News(10 mins):Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3
... Brompton Hospital helps in determining the risk of sudden death ... process involves injecting a dye called gadolinium into the patient's ... Resonance Imaging). ,The scan indicates heart scar ... which otherwise will go undetected. With DCM, the heart is ...
... that Policosanols present in Cuban sugar cane had,dramatic cholesterol-lowering ... this view. ,Two Canadian researchers Dr. Peter ... studying Nutrition and Functional Foods at the University of ... and women with high cholesterol. ,The participants ...
... May, 2006 there are 57 million underweight children in ... Government under the National Rural Health Mission (NRHM) to ... ,1. Implementing the Integrated Management of Childhood Illnesses (IMNC) ... and childhood illnesses and malnutrition. ,2. ...
... previous health campaigns on AIDS and smoking gives them enough ... problem in Australia. He was clear that introducing legislation to ... basic sense of self discipline is absent. ,Mr. ... with the challenge of obesity. It is something that has ...
... overweight children may have sleep problems that regular physical ... published in the November issue of Obesity shows a ... positive for sleep-disordered breathing, including telltale snoring. ... activity such as jumping rope, basketball and tag games, ...
... Pinpointing reasons behind the dramatic increase in testicular cancer, ... men, is the focus of a// five-year, $5.5 million ... researcher Tongzhang Zheng. , ,Testicular cancer ... provide important information on possible environmental, genetic and other ...
Cached Medicine News:Health News:Sleep Problems in Overweight Children Appear Fairly Common 2Health News:Sleep Problems in Overweight Children Appear Fairly Common 3Health News:An Eye on Increase in Testicular Cancer 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: